Sequential Combination of Antisense Oligonucleotide AHB-137 Followed by HBV Vaccine Leads to HBsAg Loss and Seroconversion in the AAV-HBV Mice

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Sequential Combination of Antisense Oligonucleotide AHB-137 Followed by HBV Vaccine Leads to HBsAg Loss and Seroconversion in the AAV-HBV Mice

	EASL 2026 May 26-30 Barcelona Jihai. Lei1*,